Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 1.05p 255,400 08:00:00
Bid Price Offer Price High Price Low Price Open Price
1.00p 1.10p 1.05p 1.05p 1.05p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.94 -2.10 -0.70 5.2

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Share Charts

1 Year Deltex Medical Chart

1 Year Deltex Medical Chart

1 Month Deltex Medical Chart

1 Month Deltex Medical Chart

Intraday Deltex Medical Chart

Intraday Deltex Medical Chart

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
10/12/201813:06Deltex Medical - a British success story!9,635
19/6/201811:15Deltex Medical interview with new CEO1
06/6/201820:52Interview with Deltex Medical Group 1
23/1/201808:47Deltex Medical - winner or doomed to fail? 180
14/7/201410:16Deltex Medical-Optimal Growth Stock10,005

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Deltex Medical Daily Update: Deltex Medical Group is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 1.05p.
Deltex Medical Group has a 4 week average price of 1.03p and a 12 week average price of 1.03p.
The 1 year high share price is 2.75p while the 1 year low share price is currently 0.70p.
There are currently 492,663,367 shares in issue and the average daily traded volume is 252,077 shares. The market capitalisation of Deltex Medical Group is £5,172,965.35.
arf dysg: The share-price fall may have been stayed but that does not mean that the buyers are staid.
arf dysg: It is 16:29 and all the share-price graphs have disappeared, except for today's. Does this indicate the start of the zombie apocalypse? If the zombies start dancing to Caribbean music, will that be the zombie apocalypso? [note spelling]
arf dysg: I like the way the six-month share-price graph ignores the dizzy heights of previous times, so it looks as if the recent behaviour of the share price is an ABSOLUTELY MASSIVE INCREASE. The trend is clearly to INFINITY and BEYOND!!!!!!!!
arf dysg: We're up! We're up! The share price is higher than it has been for weeks! We're saved, saved, SAVED I tell you!
yump: I think he might have bought because on any sign of profit in the next 5 years, this share price will be peanuts. Depends what your average price is of course. For the placees its very low. Directors have longer timescales than pi's. If you thought you'd got a chance of profit in say 3 years, you'd just stick a few figures in and then see what 1.5p looked like as a share price. We can do that as well, although its not much consolation if your average is 10p (I have no idea what mine is as stopped taking any notice a while ago!)
wigwammer: Reason to be bullish - Ewan Phillips has bought shares for the first time in years. Looking at the share price - he has been right to abstain up until now, so this may prove a tipping point. For all the discussion, argument, optimism, disappointment on display on this board over the years - I suspect there is less than handful of people who really know what is going on. EP is one of them.
orange1: They have put out the good news and on the basis of the hike in the share price will now seek to raise some money. Incidentally, why is it that so often on the day or thereabouts that DEMG make an announcement LID does the same? It is uncanny. Today is no exception.
yump: If they are actually moving towards break even, they'll find it fairly easy to raise a few hundred thousand. With the share price though, I think what will happen is that the vulture traders who buy shares where the share price has bombed, will do their best to get as many pi's as possible to sell out, by talking about liquidation, cash flow etc. etc., driving the share price artifically low. Then they'll buy in for a quick 50-100% when a few test buys move the price up. When it moves up suddenly, there'll be a bit of ramping and it will look credible, so some gullible pi's will also buy. Allowing the traders to sell out for a nice profit. Also, as always, it will attract anyone who has now been 'proved right', despite originally having dodgy arguments, although they would never have appeared ever again if they had been proved wrong. That would require too much integrity.
february 30th: Deltex probably needs $5m, so that it stops living under the shadow of the next funding, which it has always done. It also needs a new management team. Of course I believe the company should be sold. The Count questioned my view, but Deltex does not have the resources to sell its products in sufficient quantity. In terms of shareholders' best interests, the share price is I think going nowhere in the foreseeable future, and I think this was underpinned by the rather downbeat webinar. Nothing is going to happen, there is nothing to look forward to. And as the company will have to raise money soon - it always has to raise money soon - the condition of the stock market and the share price matters. The market is almost certainly going to substantially correct in the next year or two, sooner than the Deltex story is going to turn bullish. This means that funds will be impossible to get hold of at a reasonable rate, and Deltex will be facing massive dilution. Shareholders might not be happy selling their shares for 6p or less, but the correction will provide better opportunities than Deltex ever did. As far as other strategies are concerned, getting rid of the current management, combined with a large fund-raising, that increases the shares in issue by at least 50%, and perhaps 100%, might be an alternative. Ideally the company's listing would shift to the US, and maybe the CEO should be young, hungry and totally familiar with the US health system - and prepared to take risks. By the way, why am I still holding? I think the only reason to buy the share, aside from any short-term trading opportunities that occasionally arise, is for the possibility of a take-over. The main asset is clearly good, but its quality is largely negated by Deltex's mediocre management. In this light, and also with possible reference to Lidco, I came across this quotation from Keith Neumeyer, who is CEO of a silver miner: "The first thing I do is look at the management team. I know that a good management team could make a marginal asset quite exciting while a poor management team could destroy a great asset".
doglover2003: -- > Feb 30th DEMG management would certainly defend the company very determinedly and would not be recommending any offer to shareholders unless of several multiples of turnover and payable 100 per cent in cash. Therefore, I think you would find that DEMG management would make the Optimise Trial a very important issue for LIDCO shareholders. Any offer by LIDCO would probably produce a re-rating of DEMG and a hammering for LIDCO share price which would make the whole takeover unworkable. Even today LIDCO failed to produce evidence in support of their technology without mentioning DEMG in the same breadth as part of the trial. As for the DEMG share price, the substantial fall in the share price took place on very modest volumes. Conversely, it would not take mega volume to move the price in the opposite direction. DL
Deltex Medical share price data is direct from the London Stock Exchange
Your Recent History
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181218 14:48:58